Salt Lake City Angels Invests in Freyya
September 4, 2025
Salt Lake City Angels is proud to invest in Freyya, a women’s health medical device company developing a wearable, real-time rehabilitation device to monitor pelvic floor therapy for improved outcomes.
One in 4 women experiences pelvic floor disorders (PFD), and poor access to physical therapy limits treatment. Freyya is addressing PFDs with their sensor-embedded wearable that measures pelvic floor support and loading, then transmits these measurements wirelessly to a smart device, providing real-time feedback to the user and remotely to the healthcare provider.
Congrats to CEO Gabriele Niederauer, PhD, and the Freyya team on this exciting milestone.
Visit: www.freyya.com to learn more about our newest portfolio company.
And also visit www.slcangels.org to learn more about our organization.
Recent News
- RefloDx Closes $2 Million Seed Round to Advance Noninvasive Testing for Chronic Throat and Voice Symptoms
- Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers
- Ultragenyx sells second rare pediatric PRV in a week for $203M
- Co-Diagnostics’ Joint Venture CoMira Diagnostics Invited by Saudi Ministry to Participate in Strategic Manufacturing Forum
- Route 92 Medical Announces $100 Million Corporate Debt Facility
- Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp
